Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Vogel, A Cervantes, I Chau, B Daniele… - Annals of …, 2018 - annalsofoncology.org
The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last
20 years and is expected to increase until 2030 in some countries including the United …
20 years and is expected to increase until 2030 in some countries including the United …
[PDF][PDF] Achievement of complete response and drug-free status by atezolizumab plus bevacizumab combined with or without curative conversion in patients with …
M Kudo, T Aoki, K Ueshima, K Tsuchiya, M Morita… - Liver cancer, 2023 - karger.com
Introduction: Atezolizumab plus bevacizumab therapy is extremely effective in the treatment
of intermediate-stage hepatocellular carcinoma (HCC), with a response rate of 44%, as …
of intermediate-stage hepatocellular carcinoma (HCC), with a response rate of 44%, as …
Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning
YQ Jiang, SE Cao, S Cao, JN Chen, GY Wang… - Journal of cancer …, 2021 - Springer
Purpose Microvascular invasion (MVI) is a valuable predictor of survival in hepatocellular
carcinoma (HCC) patients. This study developed predictive models using eXtreme Gradient …
carcinoma (HCC) patients. This study developed predictive models using eXtreme Gradient …
[HTML][HTML] Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a …
LT Chen, E Martinelli, AL Cheng, G Pentheroudakis… - Annals of …, 2020 - Elsevier
The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma …
Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma …
Preoperative prediction power of imaging methods for microvascular invasion in hepatocellular carcinoma: a systemic review and meta-analysis
J Huang, W Tian, L Zhang, Q Huang, S Lin… - Frontiers in …, 2020 - frontiersin.org
Background: To compare the predictive power between radiomics and non-radiomics
(conventional imaging and functional imaging methods) for preoperative evaluation of …
(conventional imaging and functional imaging methods) for preoperative evaluation of …
Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma
Y Li, Y Zhang, Q Fang, X Zhang, P Hou, H Wu… - European journal of …, 2021 - Springer
As a reliable preoperative predictor for microvascular invasion (MVI) and disease-free
survival (DFS) is lacking, we developed a radiomics nomogram of [18 F] FDG PET/CT to …
survival (DFS) is lacking, we developed a radiomics nomogram of [18 F] FDG PET/CT to …
[HTML][HTML] Identification and validation of a prognostic model based on three MVI-related genes in hepatocellular carcinoma
Y Tang, L Xu, Y Ren, Y Li, F Yuan, M Cao… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
MVI has significant clinical value for treatment selection and prognosis evaluation in
hepatocellular carcinoma (HCC). We aimed to construct a model based on MVI-Related …
hepatocellular carcinoma (HCC). We aimed to construct a model based on MVI-Related …
Contrast‐enhanced CT radiomics for preoperative evaluation of microvascular invasion in hepatocellular carcinoma: a two‐center study
X Zhang, S Ruan, W Xiao, J Shao… - Clinical and …, 2020 - Wiley Online Library
Background The present study constructed and validated the use of contrast‐enhanced
computed tomography (CT)‐based radiomics to preoperatively predict microvascular …
computed tomography (CT)‐based radiomics to preoperatively predict microvascular …
Experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging
Background. Median survival in patients with hepatocellular carcinoma (HCC) and portal
vein tumor thrombosis (PVTT) is 2–6 months; conventionally liver transplantation is …
vein tumor thrombosis (PVTT) is 2–6 months; conventionally liver transplantation is …
Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
P Nie, G Yang, N Wang, L Yan, W Miao, Y Duan… - European journal of …, 2021 - Springer
Purpose Lymphovascular invasion (LVI) impairs surgical outcomes in lung adenocarcinoma
(LAC) patients. Preoperative prediction of LVI is challenging by using traditional clinical and …
(LAC) patients. Preoperative prediction of LVI is challenging by using traditional clinical and …